Low-dose bevacizumab induces radiographic regression of vestibular schwannomas in neurofibromatosis type 2: A case report and literature review

The current case study aimed to explore the efficacy of a low-dose bevacizumab regimen in inhibiting tumor growth and minimizing adverse effects. A 55-year-old man with neurofibromatosis type 2 (NF2) suffered bilateral vestibular schwannomas (VS) measuring 5.25 and 2.54 cm(3) on the left and right,...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, PENGFEI, YAO, QINGYU, LI, NA, LIU, YONGLIANG, WANG, YUGUO, LI, MENG, LI, ZEFU, LI, JIANMIN, LI, GANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840682/
https://www.ncbi.nlm.nih.gov/pubmed/27123050
http://dx.doi.org/10.3892/ol.2016.4347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840682/
https://www.ncbi.nlm.nih.gov/pubmed/27123050
http://dx.doi.org/10.3892/ol.2016.4347

Ejemplares similares